|
DHG: Explanation for business result in Q2/08
DHG Pharmaceutical Joint – Stock Company (DHG Pharma) has explained business result in Q2/08 as follows:
|
|
Q1/2008 |
Q2/2008 |
Difference |
Rate |
|
Interest payment |
1,460,840,518 |
2,309,413,906 |
848,573,388 |
58% |
|
Devaluation provision of securities investment |
|
8,404,312,420 |
8,404,312,420 |
100% |
|
Difference of exchange rate |
439,714,671 |
8,634,944,493 |
8,195,229,822 |
1864% |
|
Total |
1,900,555,189 |
19,348,670,819 |
17,448,115,630 |
|
Financial expenses increased because of the following reasons:
1. Due to the unstability of the securities market, the company has deducted for devaluation provision of securities investment as VND8,404,312,420.
2. Imported material price increased due to increase of exchange rate of VND and USD. It rose by 1864% compared to that in Q1/08.
HoSE
|
